"Acromegaly" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80)
Descriptor ID |
D000172
|
MeSH Number(s) |
C05.116.132.082 C10.228.140.617.738.250.100 C19.700.355.179
|
Concept/Terms |
Acromegaly- Acromegaly
- Somatotropin Hypersecretion Syndrome (Acromegaly)
- Hypersecretion Syndrome, Somatotropin (Acromegaly)
- Hypersecretion Syndromes, Somatotropin (Acromegaly)
- Somatotropin Hypersecretion Syndromes (Acromegaly)
- Syndrome, Somatotropin Hypersecretion (Acromegaly)
- Syndromes, Somatotropin Hypersecretion (Acromegaly)
- Inappropriate GH Secretion Syndrome (Acromegaly)
- Inappropriate Growth Hormone Secretion Syndrome (Acromegaly)
|
Below are MeSH descriptors whose meaning is more general than "Acromegaly".
Below are MeSH descriptors whose meaning is more specific than "Acromegaly".
This graph shows the total number of publications written about "Acromegaly" by people in this website by year, and whether "Acromegaly" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 0 | 1 | 1 |
2009 | 1 | 1 | 2 |
2010 | 1 | 0 | 1 |
2011 | 0 | 1 | 1 |
2018 | 1 | 0 | 1 |
2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Acromegaly" by people in Profiles.
-
Samson SL, Nachtigall LB, Fleseriu M, Jensterle M, Manning PJ, Elenkova A, Molitch ME, Ludlam WH, Patou G, Haviv A, Biermasz NR, Giustina A, Strasburger CJ, Kennedy L, Melmed S. Durable biochemical response and safety with oral octreotide capsules in acromegaly. Eur J Endocrinol. 2022 Dec 01; 187(6):733-741.
-
Martini AE, Zolton JR, DeCherney AH. Isolated Absent Thelarche in a Patient With Neurofibromatosis Type 1 and Acromegaly. Obstet Gynecol. 2018 01; 131(1):96-99.
-
Wade AN, Baccon J, Grady MS, Judy KD, O'Rourke DM, Snyder PJ. Clinically silent somatotroph adenomas are common. Eur J Endocrinol. 2011 Jul; 165(1):39-44.
-
Campbell PG, Kenning E, Andrews DW, Yadla S, Rosen M, Evans JJ. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas. Neurosurg Focus. 2010 Oct; 29(4):E5.
-
Medel R, Crowley RW, Hamilton DK, Dumont AS. Endovascular obliteration of an intracranial pseudoaneurysm: the utility of Onyx. J Neurosurg Pediatr. 2009 Nov; 4(5):445-8.
-
Ahmed I, Jabbour SA. Visual vignette. Endocr Pract. 2009 Nov-Dec; 15(7):766.
-
Jabbour SA. Cutaneous manifestations of endocrine disorders: a guide for dermatologists. Am J Clin Dermatol. 2003; 4(5):315-31.